XML 63 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Share-Based Compensation - Summary of the Option Unit Activity (Details)
 6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted Average Remaining Contractual Term, Grants Vested 1 year 7 months 6 days
2021 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 4,311,662
Number of units, granted | shares 316,262
Number of grants, forfeited | shares (43,565)
Number of units, grant outstanding ending balance | shares 4,584,359
Number of grants, vested | shares 1,523,812
Number of grants, unvested | shares 3,060,547
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 15.24
Weighted average exercise price, grants issued | $ / shares 12.86
Weighted average exercise price, forefeited | $ / shares 16.12
Weighted average exercise price, grant outstanding ending balance | $ / shares 15.06
Weighted average exercise price, grants vested | $ / shares 15.16
Weighted average exercise price, grants unvested | $ / shares $ 15.01
Weighted Average Remaining Contractual Term, Grants Outstanding 8 years 3 months 18 days
Weighted Average Remaining Contractual Term, Grants Vested 8 years 1 month 6 days
Aggregate Intrinsic Value, grants outstanding | $ $ 2,600,000
Aggregate Intrinsic Value, grants vested | $ $ 600
First Advantage Corporation [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Number of units, grant outstanding beginning balance | shares 2,843,342
Number of grants, exercised | shares (191,564)
Number of grants, forfeited | shares (424,742)
Number of units, grant outstanding ending balance | shares 2,227,036
Number of grants, vested | shares 702,197
Number of grants, unvested | shares 1,524,839
Weighted average exercise price, grant outstanding beginning balance | $ / shares $ 6.66
Weighted average exercise price, grants issued | $ / shares 6.67
Weighted average exercise price, forefeited | $ / shares 6.7
Weighted average exercise price, grant outstanding ending balance | $ / shares 6.65
Weighted average exercise price, grants vested | $ / shares 6.63
Weighted average exercise price, grants unvested | $ / shares $ 6.66
Weighted Average Remaining Contractual Term, Grants Outstanding 6 years 8 months 12 days
Weighted Average Remaining Contractual Term, Grants Vested 6 years 8 months 12 days
Aggregate Intrinsic Value, grants outstanding | $ $ 19,500,000
Aggregate Intrinsic Value, grants vested | $ $ 6,200,000